labetalol has been researched along with flunarizine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Affrime, MB; Ganes, DA; Gonzalez-Younes, I; Midha, KK; Olson, LD; Patrick, JE; Sackellares, JC; Wagner, JG | 1 |
Bonavita, E | 1 |
4 other study(ies) available for labetalol and flunarizine
Article | Year |
---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.
Topics: Algorithms; Diazepam; Flunarizine; Flurbiprofen; Humans; Labetalol; Mesoridazine; Models, Theoretical; Pharmacokinetics | 1991 |
Combined labetalol plus flunarizine treatment for arterial hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cinnarizine; Drug Therapy, Combination; Ethanolamines; Female; Flunarizine; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Piperazines; Vascular Diseases | 1984 |